Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886744-25-000071
Filing Date
2025-11-07
Accepted
2025-11-07 16:11:21
Documents
63
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20250930.htm   iXBRL 10-Q 1661316
2 EX-31.1 gern-20250930xexx311.htm EX-31.1 10234
3 EX-31.2 gern-20250930xexx312.htm EX-31.2 10306
4 EX-32.1 gern-20250930xexx321.htm EX-32.1 5077
5 EX-32.2 gern-20250930xexx322.htm EX-32.2 5115
  Complete submission text file 0000886744-25-000071.txt   7081363

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20250930.xsd EX-101.SCH 44347
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20250930_cal.xml EX-101.CAL 66926
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20250930_def.xml EX-101.DEF 213421
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20250930_lab.xml EX-101.LAB 584563
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20250930_pre.xml EX-101.PRE 386557
66 EXTRACTED XBRL INSTANCE DOCUMENT gern-20250930_htm.xml XML 1012039
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 251462772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)